Status:
ENROLLING_BY_INVITATION
The Use of Focused Ultrasound and DCE K-trans Imaging to Evaluate Permeability of the Blood-Brain Barrier
Lead Sponsor:
Neurological Associates of West Los Angeles
Conditions:
Low Grade Glioma of Brain
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The limitation of treating intrinsic brain pathologies has been circumvented with neurosurgical techniques; however, less invasive approaches may be desirable particularly for widespread or multifocal...
Detailed Description
Treatment of intrinsic brain diseases is challenging because brain barrier (BBB) limits the delivery of drugs, particulates and cellular elements such as stem cells to the central nervous system (CNS)...
Eligibility Criteria
Inclusion
- Subjects undergoing routine, repetitive MRI scanning for monitoring low grade gliomas
- 18 or older
Exclusion
- • Cognitive decline with mild cognitive impairment (Clinical Dementia Rating stage 0.5) through moderate dementia CDR stages 1 and 2
Key Trial Info
Start Date :
June 11 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 20 2027
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT04063514
Start Date
June 11 2021
End Date
January 20 2027
Last Update
March 24 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Neurological Associates of West LA
Santa Monica, California, United States, 90403